Change in clinical differences from baseline to 2 months and follow-up (6 months)
| Within-group differences from baseline (95% CI) | Between-group differences | |||||
| HBPR (n=33) | Control (n=30) | HBPR minus control | ||||
| End rehabilitation minus baseline (n=27) | 6 months minus end rehabilitation (n=19) | End rehabilitation minus baseline (n=28) | 6 months minus end rehabilitation (n=18) | End rehabilitation minus baseline | 6 months minus end rehabilitation | |
| ISWT m | 60.94±119.79 (21.84–100.04)* | −32.39±50.63 (−80.08–10.49) | −26.97±80.15 (−65.37–11.42) | 31.55±131.74 (−13.67–78.85) | 87.91 (32.98–142.85)# | −63.94 (−129.87–1.99) |
| ESWT min | 4.62±5.43 (2.88–6.35)* | −0.14±3.82 (−2.88–2.60) | 0.26±3.34 (−1.44–1.96) | 0.43±7.47 (−2.38–3.25) | 4.36 (1.93–6.79)# | −0.57 (−4.50–3.35) |
| MIST total steps | 66.11±87.86 (38.80–93.42)* | −32.73±54.08 (−54.30– −11.16)¶ | −15.24±40.47 (−42.02–11.54) | −3.99±28.46 (−28.45–20.47) | 81.35 (43.10–119.60)# | −28.74 (−61.35–3.88) |
| Daily steps | 735.76±3114.20 (−275.40–1746.61) | −815.90±4359.73 (−2501.33–869.54) | −592.70±2032.41 (−1585.63–400.24) | −834.05±2614.79 (−2565.67–897.57) | 1328.45 (−88.72–2745.61) | −18.15 (−2398.30–2434.59) |
| Quadriceps strength kg-force | 4.90±7.63 (2.24–7.56)* | −3.06±8.67 (−6.78–0.66) | −0.82±6.09 (−3.43–1.79) | −0.24±7.19 (−4.07–3.58) | 5.72 (1.99–9.45)# | −2.82 (−8.15–2.51) |
Data are presented as mean±sd (95% CI). HBPR: home-based pulmonary rehabilitation; ISWT: incremental shuttle walk test; ESWT: endurance shuttle walk test; MIST: modified incremental step test. *: p<0.05 versus baseline; #: p<0.05 between groups; ¶: p<0.05 versus end rehabilitation.